Literature DB >> 16458265

Microinjection of the L-type calcium channel antagonist diltiazem into the ventral nucleus accumbens shell facilitates cocaine-induced conditioned place preferences.

Elena H Chartoff1, Andrea M Pliakas, William A Carlezon.   

Abstract

BACKGROUND: Calcium (Ca2+) influx within the nucleus accumbens shell (NASh) can influence brain reward processes. We found previously that rats self-administer NMDA receptor antagonists (which block Ca2+ influx through NMDA receptors) into the NASh. We also found that manipulations which increase expression of Ca2+-permeable AMPA receptors within this region make cocaine aversive. Here we examined if Ca2+ influx via L-type Ca2+ channels within the NASh would influence cocaine reward.
METHODS: Rats received bilateral microinjections of the L-type Ca2+ channel antagonist diltiazem into the ventral NASh prior to place conditioning with systemic cocaine.
RESULTS: Microinjections of diltiazem (10 nmol/hemisphere) into the ventral NASh facilitated the ability of a sub-threshold dose of cocaine (5.0 mg/kg) to establish place preferences, but did not affect place conditioning on their own (5.0-40 nmol/hemisphere). Microinjections into more dorsal regions had no effects.
CONCLUSIONS: Blockade of Ca2+ influx through L-type channels Ca2+ within the ventral NASh increases cocaine reward.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16458265     DOI: 10.1016/j.biopsych.2005.09.024

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  9 in total

1.  Brain reward regulated by AMPA receptor subunits in nucleus accumbens shell.

Authors:  Mark S Todtenkopf; Aram Parsegian; Alipi Naydenov; Rachael L Neve; Christine Konradi; William A Carlezon
Journal:  J Neurosci       Date:  2006-11-08       Impact factor: 6.167

2.  Extinction of Contextual Cocaine Memories Requires Cav1.2 within D1R-Expressing Cells and Recruits Hippocampal Cav1.2-Dependent Signaling Mechanisms.

Authors:  Caitlin E Burgdorf; Kathryn C Schierberl; Anni S Lee; Delaney K Fischer; Tracey A Van Kempen; Vladimir Mudragel; Richard L Huganir; Teresa A Milner; Michael J Glass; Anjali M Rajadhyaksha
Journal:  J Neurosci       Date:  2017-10-31       Impact factor: 6.167

Review 3.  Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulation.

Authors:  Giovanni Addolorato; Lorenzo Leggio; F Woodward Hopf; Marco Diana; Antonello Bonci
Journal:  Neuropsychopharmacology       Date:  2011-10-26       Impact factor: 7.853

Review 4.  CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease.

Authors:  Shambhu Bhat; David T Dao; Chantelle E Terrillion; Michal Arad; Robert J Smith; Nikolai M Soldatov; Todd D Gould
Journal:  Prog Neurobiol       Date:  2012-06-15       Impact factor: 11.685

Review 5.  Cocaine-induced neuroadaptations in glutamate transmission: potential therapeutic targets for craving and addiction.

Authors:  Heath D Schmidt; R Christopher Pierce
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

Review 6.  Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis.

Authors:  William A Carlezon; Mark J Thomas
Journal:  Neuropharmacology       Date:  2008-07-15       Impact factor: 5.250

7.  Desipramine reduces stress-activated dynorphin expression and CREB phosphorylation in NAc tissue.

Authors:  Elena H Chartoff; Maria Papadopoulou; Matt L MacDonald; Aram Parsegian; David Potter; Christine Konradi; William A Carlezon
Journal:  Mol Pharmacol       Date:  2008-12-23       Impact factor: 4.436

8.  Nucleus Accumbens AMPA Receptors Are Necessary for Morphine-Withdrawal-Induced Negative-Affective States in Rats.

Authors:  Shayla E Russell; Daniel J Puttick; Allison M Sawyer; David N Potter; Stephen Mague; William A Carlezon; Elena H Chartoff
Journal:  J Neurosci       Date:  2016-05-25       Impact factor: 6.167

9.  T-type calcium channel Cav3.2 deficient mice show elevated anxiety, impaired memory and reduced sensitivity to psychostimulants.

Authors:  Giuseppe Gangarossa; Sophie Laffray; Emmanuel Bourinet; Emmanuel Valjent
Journal:  Front Behav Neurosci       Date:  2014-03-18       Impact factor: 3.558

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.